Glyphosate Under Scrutiny: Ban Debate, Health Risks, and Agricultural Impact in 2026

On April 25, 2026, the debate over glyphosate use in agriculture remains intensely contested, with public health experts and agricultural stakeholders presenting divergent views on its safety and regulatory future. A University of Washington symposium held in March 2026 brought together 17 leading researchers and advocates from the U.S., Canada and Europe who cited ‘compelling evidence’ that glyphosate can cause cancer, calling on global regulators to treat the herbicide as hazardous and limit or eliminate its use to protect public health.

The group emphasized that pesticide approval decisions should be based on a more comprehensive and unbiased suite of health effects data, specifically advocating for testing conducted by laboratories independent of the pesticide industry. They also urged regulators to publicly release all scientific evidence used in pesticide evaluations, arguing that current processes lack sufficient transparency, and independence.

After a University of Washington symposium, a group of 17 leading researchers and advocates cite ‘compelling evidence’ that glyphosate can cause cancer by Delger Erdenesanaa.

Chemical & Engineering News

These concerns come amid ongoing legal scrutiny of glyphosate-based products, particularly Roundup, which has been the subject of numerous lawsuits alleging links to cancer. As of early 2026, individuals pursuing legal action must demonstrate specific proof of exposure and corresponding health impacts, with courts evaluating scientific evidence on a case-by-case basis.

Agricultural organizations continue to highlight glyphosate’s role in modern farming, noting that over 80% of U.S. No-till soybean and corn growers rely on the herbicide for weed control. Proponents argue that restrictions without viable alternatives could disrupt conservation tillage practices and increase soil erosion, while critics maintain that long-term health and environmental risks outweigh short-term agricultural benefits.

The Environmental Protection Agency (EPA) has not issued a new regulatory decision on glyphosate as of April 2026, though previous assessments have concluded that the chemical is unlikely to pose a carcinogenic risk to humans when used according to label directions. This position contrasts sharply with the findings presented by the University of Washington-affiliated group, underscoring the ongoing scientific and regulatory divide.

Meanwhile, legislative efforts such as the Farm Incentives, Funding, and Research Act (FIFRA) reauthorization and broader initiatives like the Make America Healthy Again (MAHA) agenda have kept pesticide regulation in the national conversation. Figures including Robert F. Kennedy Jr. And ongoing corporate litigation involving Bayer (which acquired Monsanto in 2018) continue to influence public discourse around glyphosate’s safety profile.

As of April 2026, no federal ban on glyphosate has been enacted, and the herbicide remains legally available for use in the United States under existing label restrictions. However, growing pressure from public health advocates, combined with evolving scientific research and legal developments, suggests that the regulatory landscape surrounding glyphosate may continue to shift in the coming months.